research use only

TIMP3 Antibody [C11F19]

Catalog No.: F0817

    Application: Reactivity:

    Experiment Essentials

    WB
    Recommended wet transfer conditions: 200 mA, 60 min.

    Usage Information

    Dilution
    1:1000
    Application
    WB
    Reactivity
    Human, Mouse, Rat
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    20 kDa, 25 kDa
    Positive Control A-431 cell; NIH/3T3 cell
    Negative Control

    Exprimental Methods

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    Biological Description

    Specificity
    TIMP3 Antibody [C11F19] detects endogenous levels of total TIMP3 protein.
    Subcellular Location
    Extracellular matrix, Secreted
    Uniprot ID
    P35625
    Clone
    C11F19
    Synonym(s)
    Metalloproteinase inhibitor 3; Protein MIG-5; Tissue inhibitor of metalloproteinases 3 (TIMP-3); TIMP3
    Background
    Tissue inhibitor of metalloproteinases 3 (TIMP3) is a unique member of the TIMP family, encoded by the TIMP3 gene, and is notable for its strong binding affinity to the extracellular matrix (ECM) and broad inhibitory activity against matrix metalloproteinases (MMPs), ADAMs, and ADAMTSs, playing a critical role in maintaining ECM homeostasis and regulating tissue remodeling. TIMP3 protein is composed of an N-terminal domain (~120 amino acids) and a C-terminal domain, stabilized by six disulfide bonds formed between twelve conserved cysteine residues; it possesses a wedge-like shape that fits into metalloproteinase active sites to inhibit their proteolytic activities. TIMP3 inhibits angiogenesis, regulates apoptosis, and maintains ECM integrity by anchoring to matrix components, thus modulating cell-matrix interactions. It participates in signaling pathways such as NF-κB, balancing inflammation and tissue remodeling by regulating key proteins like TNF-alpha and metalloproteinases. TIMP3 dysregulation is implicated in diverse diseases, including chronic obstructive pulmonary disease (COPD), age-related macular degeneration (AMD), Sorsby’s fundus dystrophy, diabetic nephropathy, and osteoarthritis, often through disrupted ECM turnover and aberrant angiogenesis.
    References
    • https://pubmed.ncbi.nlm.nih.gov/32612540/
    • https://pubmed.ncbi.nlm.nih.gov/38601018/

    Tech Support

    Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3
    If you have any other enquiries, please leave a message.

    * Indicates a Required Field

    Please enter your name.
    Please enter your email. Please enter a valid email address.
    Please write something to us.